CFO Files Intent to Sell Additional $732K in Stock Amidst Executive Distribution
PLXS sits 90% above its 52-week low of $103.43 on elevated volume (2.9× avg).
Summary
Plexus Corp.'s CFO, Patrick Jermain, filed a Form 144 to sell an additional $732,070 in common stock, adding to a recent trend of executive share dispositions.
Key Events · Ownership and Investor Activity · PLXS
-
CFO Files Intent to Sell
Patrick Jermain, CFO, filed a Form 144 indicating intent to sell 3,587 shares of common stock, valued at approximately $732,070.
-
Follows Recent Executive Sales
This proposed sale adds to recent insider selling, including Jermain's $987,612 sale reported yesterday (2026-02-03) and the CEO's $1.67 million sale on the same day.
-
Ongoing Insider Distribution
The company has seen a net insider selling of $2.85 million over the past 90 days from 3 active insiders, signaling a broader distribution trend among executives.
Analysis · PLXS · Manufacturing
This Form 144 filing indicates Plexus Corp.'s CFO, Patrick Jermain, intends to sell an additional $732,070 worth of common stock. This proposed sale follows a recent pattern of significant insider selling, including Jermain's own $987,612 sale reported yesterday (2026-02-03) and the CEO's $1.67 million sale on the same day. While the individual proposed sale is a small percentage of the company's market capitalization, the cumulative executive distribution signals a desire for liquidity from top management. Investors should monitor further insider activity for continued selling trends.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLXS was trading at $196.28 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $103.43 to $208.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.